Replies to post #72189 on Innovation Pharmaceuticals Inc (IPIX)

[alwaysdreaming]

Food for thought, Could the reason that the dosage for Cohort 9 jumped so high be that if the benefits from that dosage are not substantially higher, they will end the trial and use Cohort 9's dosage as the endpoint?

[JUST 10-11-12]

they certainly would not need to be on IHUB!